Komishane's Pharmacy is an authorized DME supplier for medicare equipments and products.
Komishane's Pharmacy is a Pharmacy in Newark, New Jersey. This pharmacy is owned and operated by Amita Corp. It is located at 199 Stuyvesant Ave, Newark and it's customer support contact number is 973-399-0900. The authorized person of Komishane's Pharmacy is Mr. Ghansham Datwani who is President Pharmacist of the pharmacy and his contact number is 973-399-0900. Active license number of Komishane's Pharmacy is 28RS0032200 for Pharmacy in New Jersey. Komishane's Pharmacy accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Komishane's Pharmacy is a facility used by pharmacists for the compounding and dispensing of medicinal preparations and other associated professional and administrative services. A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located.
Pharmacy Details:
Komishane's Pharmacy type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Komishane's Pharmacy
Type:
Pharmacy
Location:
199 Stuyvesant Ave, Newark, New Jersey, 07106-3020
Phone:
973-399-0900
Fax:
973-399-0902
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Mr. Ghansham Datwani
Position:
President Pharmacist
Contact Number:
973-399-0900
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1174683999
NPI Enumeration Date:
11 Dec, 2006
NPI Last Update On:
28 Aug, 2014
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Komishane's Pharmacy are as mentioned below.
Specialization
License Number
State
Status
Pharmacy
28RS0032200
New Jersey
Primary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
3123976
Other
New Jersey
Nabp
Medicare Enrollment:
Komishane's Pharmacy is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
1951420512
O20100930002125
Amita Corp
DME SUPPLIER - PHARMACY
1951420512
O20140509001591
Amita Corp
PART B SUPPLIER - MASS IMMUNIZATION (ROSTER BILLER ONLY)
Products Available:
Komishane's Pharmacy has following products available for sale under medicare.
Products
Automatic External Defibrillators (aeds)
Blood Glucose Monitors & Supplies: Non-mail Order
Canes & Crutches
Commodes, Urinals, & Bedpans
Diabetic Shoes & Inserts: Custom Fabricated
Diabetic Shoes & Inserts: Prefabricated
Heat & Cold Applications
Nebulizer Equipment & Supplies
Ostomy Supplies
Seat Lift Mechanisms
Surgical Dressings
Tracheostomy Supplies
Urological Supplies
Walkers
Wheelchair Seating/cushions
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
199 Stuyvesant Ave, Newark, New Jersey
Zip:
07106-3020
Phone Number:
973-399-0900
Fax Number:
973-399-0902
Patients can reach Komishane's Pharmacy at 199 Stuyvesant Ave, Newark, New Jersey or can call on customer care at 973-399-0900.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.